Vogt–Koyanagi–Harada syndrome in the setting of COVID‐19 infection
Abstract To report a case of Vogt–Koyanagi–Harada disease (VKH) in a 27‐year‐old male 2 weeks proceeding COVID‐19 infection onset. Severe complications of VKH can be avoided by early diagnosis and adequate treatment with corticosteroids and immunosuppressants. It is possible that COVID‐19 was a pote...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2023-03-01
|
| Series: | Clinical Case Reports |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/ccr3.6617 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849329053351280640 |
|---|---|
| author | Tiffany Eatz Jude Hassan Charles |
| author_facet | Tiffany Eatz Jude Hassan Charles |
| author_sort | Tiffany Eatz |
| collection | DOAJ |
| description | Abstract To report a case of Vogt–Koyanagi–Harada disease (VKH) in a 27‐year‐old male 2 weeks proceeding COVID‐19 infection onset. Severe complications of VKH can be avoided by early diagnosis and adequate treatment with corticosteroids and immunosuppressants. It is possible that COVID‐19 was a potential immunological trigger of VKH in our patient. |
| format | Article |
| id | doaj-art-be4224a034ba48dd94b31afd5e46aa89 |
| institution | Kabale University |
| issn | 2050-0904 |
| language | English |
| publishDate | 2023-03-01 |
| publisher | Wiley |
| record_format | Article |
| series | Clinical Case Reports |
| spelling | doaj-art-be4224a034ba48dd94b31afd5e46aa892025-08-20T03:47:23ZengWileyClinical Case Reports2050-09042023-03-01113n/an/a10.1002/ccr3.6617Vogt–Koyanagi–Harada syndrome in the setting of COVID‐19 infectionTiffany Eatz0Jude Hassan Charles1Department of Neurology, Miller School of Medicine The University of Miami Miami Florida USADepartment of Neurology, Miller School of Medicine The University of Miami Miami Florida USAAbstract To report a case of Vogt–Koyanagi–Harada disease (VKH) in a 27‐year‐old male 2 weeks proceeding COVID‐19 infection onset. Severe complications of VKH can be avoided by early diagnosis and adequate treatment with corticosteroids and immunosuppressants. It is possible that COVID‐19 was a potential immunological trigger of VKH in our patient.https://doi.org/10.1002/ccr3.6617comorbidCOVID‐19infectious diseaserareVKH |
| spellingShingle | Tiffany Eatz Jude Hassan Charles Vogt–Koyanagi–Harada syndrome in the setting of COVID‐19 infection Clinical Case Reports comorbid COVID‐19 infectious disease rare VKH |
| title | Vogt–Koyanagi–Harada syndrome in the setting of COVID‐19 infection |
| title_full | Vogt–Koyanagi–Harada syndrome in the setting of COVID‐19 infection |
| title_fullStr | Vogt–Koyanagi–Harada syndrome in the setting of COVID‐19 infection |
| title_full_unstemmed | Vogt–Koyanagi–Harada syndrome in the setting of COVID‐19 infection |
| title_short | Vogt–Koyanagi–Harada syndrome in the setting of COVID‐19 infection |
| title_sort | vogt koyanagi harada syndrome in the setting of covid 19 infection |
| topic | comorbid COVID‐19 infectious disease rare VKH |
| url | https://doi.org/10.1002/ccr3.6617 |
| work_keys_str_mv | AT tiffanyeatz vogtkoyanagiharadasyndromeinthesettingofcovid19infection AT judehassancharles vogtkoyanagiharadasyndromeinthesettingofcovid19infection |